Nexgenrx Inc (NXG.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,542 | 2,134 | 1,896 | 1,706 | 1,845 |
| Receivables | 966 | 742 | 1,040 | 874 | 1,161 |
| Other current assets | 30,013 | 26,886 | 23,825 | 21,803 | 22,054 |
| TOTAL | $33,823 | $30,024 | $26,992 | $24,655 | $25,288 |
| Non-Current Assets | |||||
| PPE Net | 883 | 941 | 797 | 826 | 765 |
| Investments And Advances | 296 | 258 | 221 | 181 | N/A |
| Intangibles | 2,933 | 3,171 | 3,338 | 3,567 | 3,757 |
| Other Non-Current Assets | 1,262 | 1,282 | 1,259 | 1,236 | 1,783 |
| TOTAL | $5,374 | $5,651 | $5,614 | $5,810 | $6,305 |
| Total Assets | $39,198 | $35,675 | $32,607 | $30,465 | $31,593 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 481 | 265 | 153 | 504 | 934 |
| Other current liabilities | 30,013 | 26,886 | 23,825 | 21,803 | 22,054 |
| TOTAL | $30,516 | $27,196 | $24,059 | $22,413 | $23,095 |
| Non-Current Liabilities | |||||
| TOTAL | $393 | $393 | $427 | $427 | $395 |
| Total Liabilities | $30,909 | $27,588 | $24,486 | $22,841 | $23,489 |
| Shareholders' Equity | |||||
| Common Shares | 4,011 | 4,011 | 4,011 | 4,011 | 4,011 |
| Retained earnings | -1,768 | -1,970 | -1,935 | -2,429 | -1,947 |
| TOTAL | $8,289 | $8,087 | $8,120 | $7,624 | $8,104 |
| Total Liabilities And Equity | $39,198 | $35,675 | $32,607 | $30,465 | $31,593 |